Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAL photodynamic therapy in low-grade cervical intraepithelial neoplasia
2008-004604-31Phase 2Completed
- Sponsor
- Photocure
- Start
- Aug 2008
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in cervical intraepithelial neoplasia (CIN) and cervical intraepithelial neoplasia grade 1 comparing HAL PDT (Cevira) with Placebo PDT (2 arms). Primary endpoint: Complete response rate at 6 months. Started Aug 2008; status: completed.
02
Drugs
Cevira
03
Conditions
cervical intraepithelial neoplasia (CIN)cervical intraepithelial neoplasia grade 1
Beyond the preview
Go deeper on 2008-004604-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004604-31.